
A woman who claimed that a hormone-replacement drug manufactured by Pfizer Inc.’s Wyeth unit caused her breast cancer has been awarded $9.45 million by a jury. The woman, Audrey Singleton, a retired school bus driver from Alabama, began taking the drug, Prempro, in August 1997 and took it until 2004.
At the time she started the drug, a mammogram came back normal. She stopped taking Prempro only after she was diagnosed with breast cancer. Singleton is one of 8,000 people suing Pfizer / Wyeth claiming that they were affected by cancer because of the drug.
The jury awarded Singleton $3.25 million in compensatory damages and $6 million in punitive damages, as well as $200,000 to Singleton’s husband for loss of consortium.
The drug Prempro is a combination of Wyeth’s estrogen-based drug Premarin and Pfizer Pharmacia & Upjohn’s progestin-based drug Provera. Prempro was prescribed to women seeking relief from symptoms like hot flashes and mood swings.
A study in 2002 linked use of the drug to cancer. Despite the study, Wyeth claims that Singleton’s doctor instructed her to continue taking Prempro.
It remains to be seen if the jury award will stand. Two other jury verdicts that found against Pfizer were reversed post-trial and others are being challenged on appeal.
Read More About $9.45 million awarded to woman in Prempro breast cancer case...
Tavss Fletcher
RBC Centura
555 East Main Street
14th Floor
Norfolk, VA 23510
Phone: 757.625.1214
Fax: 757.622.7295
Get Directions